CardioNet, Inc. and AirStrip Partner to Expand Mobile Patient Monitoring
February 13 2013 - 8:05AM
Business Wire
As health systems are under increasing pressure to share data
across systems to improve and expand their networks of care,
CardioNet, Inc. and AirStrip have entered into a partnership
agreement to develop and co-market an integrated solution for
mobile patient monitoring.
The AirStripTM mobility solution will deliver live patient data
from CardioNet’s Mobile Cardiac Outpatient TelemetryTM (MCOTTM)
directly to clinicians’ mobile devices, including tablets and
phones. This integrated solution will enable health systems to
combine critical cardiac data with EMR and device information to
improve patient monitoring and clinician decision-making at the
point of care.
“This partnership is the foundation for a powerful end-to-end
cardiac care package that promises to have a game-changing impact
on 30-day readmissions for heart failure,” said Alan Portela,
AirStrip CEO. “Our pioneering mobility solution delivers critical
patient data to physicians anywhere across the care continuum to
encourage better decision-making and improve both the timeliness
and quality of care. This integration with CardioNet’s platform
enables health systems to empower clinicians with the information
they need to achieve key quality metrics in cardiology – one of the
most resource and time-intensive practice areas within
healthcare.”
While details of the partnership agreement were not disclosed,
it is exclusive to select markets. The two companies expect to
deliver a market-ready solution by mid-year.
Joseph H. Capper, CardioNet’s President and CEO, commented:
“This collaboration is one of the most exciting initiatives
CardioNet has embarked on to date. As the leader in the mobile
cardiac telemetry market, we are always looking for avenues to
expand the utilization of our data. The AirStrip solution is the
leading FDA-cleared technology for the transmission of virtual,
live ECG waveforms to a healthcare provider’s mobile device. This
solution is rapidly transforming the way clinical data is delivered
and integrated in a point of care setting. Incorporating the
timely, accurate information derived from MCOTTM into AirStrip’s
state-of-the-art mobile system will undoubtedly improve the
physician’s ability to deliver the proper treatment, the first
time.”
Tweet This: @AirStripmHealth and @CardioNetMCOT partner to
enable mobile patient monitoring in cardiac care
About CardioNet, Inc.
CardioNet is the leading provider of ambulatory, continuous,
real-time outpatient management solutions for monitoring relevant
and timely clinical information regarding an individual’s health.
CardioNet’s initial efforts are focused on the diagnosis and
monitoring of cardiac arrhythmias, or heart rhythm disorders, with
a solution that it markets as Mobile Cardiac Outpatient Telemetry™
(MCOT™). Through its Cardiocore division, CardioNet is offers core
lab services to pharmaceutical and devise sponsors as they mover
new products through the development process. More information can
be found at http://www.cardionet.com.
About AirStrip
AirStrip (www.airstriptech.com) provides healthcare’s only
complete, vendor- and data source-agnostic enterprise-wide clinical
mobility solution, which enables clinicians to improve the health
of individuals and populations. With deep clinical expertise and
strong roots in mobile technology and data integration, AirStrip is
empowering the nation’s leading health systems as the industry
continues to evolve to new business models, accountable care and
shared risk. Based in San Antonio, Texas, AirStrip allows health
systems to unlock the full potential of their existing technology
investments with a complete mobility solution that provides access
to critical patient data across the care continuum. AirStrip is
backed by investments from Sequoia Capital, Qualcomm, Inc.,
Hospital Corporation of America (HCA) and the Wellcome Trust.
Follow AirStrip
- Blog: www.MobileHealthMatters.com
- Twitter: @AirStripmHealth
- LinkedIn:
www.linkedin.com/company/airstrip-technologies
CARDIONET CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS
This document includes certain forward-looking statements within
the meaning of the “Safe Harbor” provisions of the Private
Securities Litigation Reform Act of 1995 regarding, among other
things, our growth prospects, the prospects for our products and
our confidence in the Company’s future. These statements may be
identified by words such as “expect,” “anticipate,” “estimate,”
“intend,” “plan,” “believe,” “promises” and other words and terms
of similar meaning. Such forward-looking statements are based on
current expectations and involve inherent risks and uncertainties,
including important factors that could delay, divert, or change any
of these expectations, and could cause actual outcomes and results
to differ materially from current expectations. These factors
include, among other things, the effect of the Cardiocore
acquisition on our business operations and financial results and
our ability to successfully integrate its operations into our
business, the national rate set by the Centers for Medicare and
Medicaid Services (“CMS”) for our mobile cardiovascular telemetry
service, effects of changes in health care legislation,
effectiveness of our cost savings initiatives, relationships with
our government and commercial payors, changes to insurance coverage
and reimbursement levels for our products, the success of our sales
and marketing initiatives, our ability to attract and retain
talented executive management and sales personnel, our ability to
identify acquisition candidates, acquire them on attractive terms
and integrate their operations into our business, our ability to
develop and co-market an integrated telemetry platform with
Airstrip Technologies, Inc., the commercialization of new products,
market factors, internal research and development initiatives,
partnered research and development initiatives, competitive product
development, changes in governmental regulations and legislation,
the continued consolidation of payors, acceptance of our new
products and services, patent protection, adverse regulatory
action, and litigation success. For further details and a
discussion of these and other risks and uncertainties, please see
our public filings with the Securities and Exchange Commission,
including our latest periodic reports on Form 10-K and 10-Q. We
undertake no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events,
or otherwise.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024